跳至主要内容
临床试验/CTRI/2024/09/073812
CTRI/2024/09/073812尚未招募2 期

Standard controlled clinico-comparative study of Virechana followed by Shamana with lifestyle management in Amlapitta(GERD)

Astha Shukla1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年9月23日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
Relief in the symptoms of Amlapitta described below-

研究概览

简要总结

The study is a open,randomised clinical trial to evaluate and compare the efficacy of virechana followed by shaman,modern drug and lifestyle management in Amlapitta(GERD) for the age group 16-60 years for 48 days.This study will be conducted at UAU,Gurukul Campus,Haridwar including 90 patients.Assessment will be done on the basis of subjective criteria.Study will be done on OPD/IPD level of Panchakarma department.One group will be given virechana followed by shaman dravya for 24 days.second group will be given omeprazole capsules for 48 days and third group will be given placebo treatment along with lifestyle management for 48 days.Followup will be done after 1 month .results will be analysed using appropriate tests.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Classical symptoms of Amlapitta as described in Ayurvedic texts viz.
  • Hridkantha Daah (burning sensation in epigastric region), Aruchi (loss of appetite).
  • Utklesha (Nausea), Tiktaamla Udgaar (Acid regurgitation), Udar Adhmana (Flatulence), Avipaaka (Indigestion).
  • GERD (Hyperacidity) without any complications.
  • Patients between age group 16-60 years will be selected for the study.
  • Patients who are fit for Virechana Karma.
  • Patients who are willing to give written consent.

排除标准

  • 1.Patients suffering from severe diseases like uncontrolled diabetes, renal disease, liver disease and cardiovascular disease (uncontrolled HTN).
  • Patients who are unfit for Virechana Karma.
  • Lactating and pregnant women.

结局指标

主要结局

Relief in the symptoms of Amlapitta described below-

时间窗: 48 days

Daha,Amlodgara,Shula,Chardi,Avipaka,Aruchi

时间窗: 48 days

次要结局

  • Relief in the symptoms of Amlapitta described below-(Daha,Amlodgara,Shula,Chardi,)

研究者

发起方
Astha Shukla
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Astha Shukla

Uttarakhand Ayurveda university,Gurukul campus,Haridwar

研究点 (1)

Loading locations...

相似试验